Literature DB >> 9250408

Oxidation of low-density lipoproteins produces levuglandin-protein adducts.

R G Salomon1, G Subbanagounder, U Singh, J O'Neil, H F Hoff.   

Abstract

Free-radical oxidation of human low-density lipoprotein (LDL) produces levuglandin (LG)-protein adducts that were detected with an enzyme-linked immunosorbent assay using LGE2-KLH antibodies which recognize LGE2-derived pyrroles. The level of immunoreactivity increases with time of oxidation and reaches a maximum by 8 h. The yield of pyrrole varies nonlinearly with the level of LG adduction to LDL. At low LG:LDL ratios, such as those detected in oxidized LDL, the reaction of primary amino groups with LGE2 produces mostly non-pyrrole adducts that are not immunoreactive. Concomitant phospholipolysis must occur if the generation of immunoreactive epitopes in LDL involves oxidation of arachidonyl phospholipids. Thus, since a protein adduct prepared from synthetic LGE2-2-lysophosphatidylcholine ester showed, at most, only 0.5% cross-reactivity with the LGE2-KLH antibodies, the epitopes detected in oxidized LDL are almost certainly not protein adducts of LG-phospholipid esters. As expected, hydrolysis of the carboxylic ester in the protein adduct of LGE2-2-lysophosphatidylcholine ester by treatment with phospholipase A2 produced a fully immunoreactive LGE2-protein adduct.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250408     DOI: 10.1021/tx970016b

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  21 in total

1.  Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D2.

Authors:  Yu-Shiuan Cheng; Wenyuan Yu; Yunfeng Xu; Robert G Salomon
Journal:  J Nat Prod       Date:  2017-02-14       Impact factor: 4.050

2.  Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.

Authors:  Aicha Saadane; Natalia Mast; Casey D Charvet; Saida Omarova; Wenchao Zheng; Suber S Huang; Timothy S Kern; Neal S Peachey; Irina A Pikuleva
Journal:  Am J Pathol       Date:  2014-07-25       Impact factor: 4.307

3.  A liquid chromatography-tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines.

Authors:  Lilu Guo; Venkataraman Amarnath; Sean S Davies
Journal:  Anal Biochem       Date:  2010-06-19       Impact factor: 3.365

4.  Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.

Authors:  Lilu Guo; Zhongyi Chen; Venkataraman Amarnath; Patricia G Yancey; Brian J Van Lenten; Justin R Savage; Sergio Fazio; MacRae F Linton; Sean S Davies
Journal:  Antioxid Redox Signal       Date:  2015-03-18       Impact factor: 8.401

Review 5.  Role of phospholipid oxidation products in atherosclerosis.

Authors:  Sangderk Lee; Konstantin G Birukov; Casey E Romanoski; James R Springstead; Aldons J Lusis; Judith A Berliner
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

6.  Molecular Structures of Isolevuglandin-Protein Cross-Links.

Authors:  Wenzhao Bi; Geeng-Fu Jang; Lei Zhang; John W Crabb; James Laird; Mikhail Linetsky; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-09-21       Impact factor: 3.739

7.  Isoketals form cytotoxic phosphatidylethanolamine adducts in cells.

Authors:  C Blake Sullivan; Elena Matafonova; L Jackson Roberts; Venkataraman Amarnath; Sean S Davies
Journal:  J Lipid Res       Date:  2009-11-25       Impact factor: 5.922

8.  Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1.

Authors:  Casey D Charvet; James Laird; Yunfeng Xu; Robert G Salomon; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

9.  Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.

Authors:  Wei Li; James M Laird; Liang Lu; Sanjoy Roychowdhury; Laura E Nagy; Rong Zhou; John W Crabb; Robert G Salomon
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

10.  Characterization of a human apolipoprotein a-I construct expressed in a bacterial system.

Authors:  Eduardo Daniel Prieto; Nahuel Ramella; Luz Angela Cuellar; María Alejandra Tricerri; Horacio Alberto Garda
Journal:  Protein J       Date:  2012-12       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.